Copyright © 2005 Cell Press. All rights reserved.
Cell Metabolism, Vol 1, 245-258, April 2005

Article

The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse

Pär Steneberg,1 Nir Rubins,2,3 Reut Bartoov-Shifman,2 Michael D. Walker,2,* and Helena Edlund1,*

1 Umeå Center for Molecular Medicine, University of Umeå, SE-901 87 Umeå, Sweden
2 Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel

*Corresponding author
Helena Edlund
Ph: 090-785-4429
F: 090-785-4400 [H.E.]
m.walker@weizmann.ac.il

*Corresponding author
Michael D. Walker
Ph: 972-8-934-3597
F: 972-8-934-4118 [M.D.W.]
helena.edlund@ucmm.umu.se


Summary


Obesity is typically associated with elevated levels of free fatty acids (FFAs) and is linked to glucose intolerance and type 2 diabetes. FFAs exert divergent effects on insulin secretion from β cells: acute exposure to FFAs stimulates insulin secretion, whereas chronic exposure impairs insulin secretion. The G protein-coupled receptor GPR40 is selectively expressed in β cells and is activated by FFAs. We show here that GPR40 mediates both acute and chronic effects of FFAs on insulin secretion and that GPR40 signaling is linked to impaired glucose homeostasis. GPR40-deficient β cells secrete less insulin in response to FFAs, and loss of GPR40 protects mice from obesity-induced hyperinsulinemia, hepatic steatosis, hypertriglyceridemia, increased hepatic glucose output, hyperglycemia, and glucose intolerance. Conversely, overexpression of GPR40 in β cells of mice leads to impaired β cell function, hypoinsulinemia, and diabetes. These results suggest that GPR40 plays an important role in the chain of events linking obesity and type 2 diabetes.

Footnotes

3 Present address: Department of Genetics, University of Pennsylvania School of Medicine, 415 Curie Boulevard, Philadelphia,  Pennsylvania 19104.

Article Options

Search Medline for

Related Articles